Name	Daptomycin
Description	Daptomycin (LY146032) is a cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
In vivo	Administering daptomycin at a dosage of 10 mg/kg twice daily significantly reduced the amount of organisms per kidney compared to infected untreated controls within 48 hours of treatment initiation. Although a 20 mg/kg dose administered once daily is less effective, it still significantly lowers colony counts after 4 days of therapy, with its efficacy being comparable to that of vancomycin or vancomycin-gentamicin administered twice daily[4].
Storage	keep away from moisture \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	H2O : 32.4 mg/mL (20 mM) DMSO : 45 mg/mL (27.77 mM)
Keywords	LY 146032 \| Bacterial \| LY-146032 \| inhibit \| Inhibitor \| Daptomycin \| Antibiotic
Related Compound Libraries	Cyclic Peptide Library \| Bioactive Compound Library \| Anti-Cancer Clinical Compound Library \| Microbial Natural Product Library \| Natural Product Library for HTS \| FDA-Approved Drug Library \| Anti-Cancer Approved Drug Library \| Anti-Aging Compound Library \| Bioactive Compounds Library Max \| Anti-Cancer Drug Library

Daptomycin NEW

Product Introduction